Insider Trading & Ownership - Brown Ryan Edward

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Brown Ryan Edward
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-01
Sale
2024-03-05
8:00 pm
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
2,000$125.34$250,68044,327
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-07
Tax Withholding
2024-03-11
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
506$120.4928,688
(Direct)
View
2024-03-08
Tax Withholding
2024-03-11
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
899$123.1428,688
(Direct)
View
2024-03-04
Tax Withholding
2024-03-06
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
1,734$125.3230,093
(Direct)
View
2024-03-01
Tax Withholding
2024-03-05
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
269$126.1944,327
(Direct)
View
2024-03-01
Option Award
2024-03-05
8:00 pm
2025-03-01
2034-03-01
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
18,500$044,327
(Direct)
View
2023-06-01
Tax Withholding
2023-06-05
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
EVP, General Counsel
89$123.628,096
(Direct)
View
2023-03-08
Tax Withholding
2023-03-10
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
635$153.1928,185
(Direct)
View
2023-03-06
Option Award
2023-03-08
8:00 pm
2024-03-06
2033-03-06
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
31,500$055,820
(Direct)
View
2023-03-06
Tax Withholding
2023-03-08
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
1,325$157.2155,820
(Direct)
View
2023-03-01
Tax Withholding
2023-03-03
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
196$147.5725,645
(Direct)
View
2022-06-01
Tax Withholding
2022-06-03
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
54$72.6725,841
(Direct)
View
2022-03-07
Option Award
2022-03-08
8:02 pm
2023-03-07
2032-03-07
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
56,000$073,895
(Direct)
View
2022-03-07
Tax Withholding
2022-03-08
8:02 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
153$79.3673,895
(Direct)
View
2022-03-04
Tax Withholding
2022-03-08
8:02 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
1,136$79.273,895
(Direct)
View
2022-03-01
Tax Withholding
2022-03-01
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
184$75.0519,184
(Direct)
View
2021-06-01
Tax Withholding
2021-06-03
4:57 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
64$76.0119,368
(Direct)
View
2021-03-03
Option Award(A)
2021-03-10
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
15,000$019,432
(Direct)
View
2021-02-28
Tax Withholding(A)
2021-03-10
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
216$86.9719,432
(Direct)
View
2021-03-04
Tax Withholding(A)
2021-03-10
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
190$80.7619,432
(Direct)
View
2021-03-03
Option Award
2021-03-05
8:02 pm
2022-03-03
2031-03-03
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
75,000$079,838
(Direct)
View

Ownership
2021-03-05
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTBrown Ryan Edward
SVP, General Counsel
0$038,093
(Direct)
View
(A) Indicate amendment filing.